Trial Profile
A randomized, double blinded placebo controlled study to investigate antimicrobial efficacy and safety following topical application of DPK-060. Final protocol dated 2007-12-19. CRO protocol no. Q-27318. Final protocol incorporating amendment 1 dated 2008-08-28. Amendment 2 dated 2008-10-01.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Dec 2018
Price :
$35
*
At a glance
- Drugs DPK 060 (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- Sponsors DermaGen
- 26 Aug 2011 New trial record